Current Ratio of Outlook Therapeutics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Outlook Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Outlook Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 48%, a 41% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 48% -34% -41% 30 Sep 2025
Q2 2025 56% -26% -32% 30 Jun 2025
Q1 2025 67% -10% -13% 31 Mar 2025
Q4 2024 78% -1% -1.3% 31 Dec 2024
Q3 2024 82% -40% -33% 30 Sep 2024
Q2 2024 82% -63% -43% 30 Jun 2024
Q1 2024 77% -108% -58% 31 Mar 2024
Q4 2023 79% -149% -65% 31 Dec 2023
Q3 2023 122% -112% -48% 30 Sep 2023
Q2 2023 144% -121% -46% 30 Jun 2023
Q1 2023 186% -68% -27% 31 Mar 2023
Q4 2022 228% -20% -8.2% 31 Dec 2022
Q3 2022 234% +60% +35% 30 Sep 2022
Q2 2022 265% +119% +81% 30 Jun 2022
Q1 2022 254% +110% +77% 31 Mar 2022
Q4 2021 249% +154% +162% 31 Dec 2021
Q3 2021 173% +94% +118% 30 Sep 2021
Q2 2021 146% +76% +109% 30 Jun 2021
Q1 2021 144% +88% +159% 31 Mar 2021
Q4 2020 95% +50% +110% 31 Dec 2020
Q3 2020 80% +42% +112% 30 Sep 2020
Q2 2020 70% +46% +189% 30 Jun 2020
Q1 2020 55% +38% +215% 31 Mar 2020
Q4 2019 45% +24% +118% 31 Dec 2019
Q3 2019 37% +7.1% +23% 30 Sep 2019
Q2 2019 24% -7.5% -24% 30 Jun 2019
Q1 2019 18% -3.3% -16% 31 Mar 2019
Q4 2018 21% +4.9% +31% 31 Dec 2018
Q3 2018 30% +24% +350% 30 Sep 2018
Q2 2018 32% +23% +268% 30 Jun 2018
Q1 2018 21% -1.4% -6.2% 31 Mar 2018
Q4 2017 16% -9.1% -36% 31 Dec 2017
Q3 2017 6.8% 30 Sep 2017
Q2 2017 8.6% 30 Jun 2017
Q1 2017 22% 31 Mar 2017
Q4 2016 25% 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.